Irinotecan Injection (Irinotel) is indicated as a component of first line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of colon or rectum. It is also indicated in the treatment of patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracilbased therapy.
PRESENTATION :
Irinotel, a sterile, light yellow clear aqueous solution, is available as 2 ml and 5 ml injection containing 40 mg and 100 mg of Irinotecan Hydrochloride trihydrate respectively at a concentration of 20 mg/ml.